Invitrogen Corporation (NASDAQ:IVGN) is a global company with revenues of $1.3 billion. We provide products and services to pharmaceutical and biotechnology companies, as well as academic and government research institutions.
More than 4,700 employees work for Invitrogen and we conduct business in over 70 countries. We offer 35,000 unique products and services to support disease research, drug discovery and commercial bio-production.
Invitrogen’s product family includes many of the most widely recommended names in the industry, including Molecular Probes, Gibco, and Dynal Biotech. Our products can be found in nearly every major laboratory in the world. Many of the greatest medical discoveries of the last two decades were made using Invitrogen products, including the discovery of the AIDS virus, advancements in Click for details>>
United States
